Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

NorthX Biologics AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 15,831 Less Arrow 9,868 More Arrow 14,282
Financial expenses 82 Less Arrow 19 More Arrow 71
Earnings before taxes -5,002 Less Arrow -6,647 More Arrow -1,055
EBITDA -3,569 Less Arrow -5,642 More Arrow -390
Total assets 28,816 More Arrow 32,372 Less Arrow 24,839
Current assets 13,980 More Arrow 14,989 Less Arrow 12,404
Current liabilities 28,699 Less Arrow 28,188 Less Arrow 24,129
Equity capital 108 More Arrow 4,185 Less Arrow 710
- share capital 9 Equal arrow 9 Equal arrow 9
Employees (average) 116 More Arrow 145 Less Arrow 129

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 0.4% More Arrow 12.9% Less Arrow 2.9%
Turnover per employee 136 Less Arrow 68 More Arrow 111
Profit as a percentage of turnover -31.6% Less Arrow -67.4% More Arrow -7.4%
Return on assets (ROA) -17.1% Less Arrow -20.5% More Arrow -4.0%
Current ratio 48.7% More Arrow 53.2% Less Arrow 51.4%
Return on equity (ROE) -4631.5% More Arrow -158.8% More Arrow -148.6%
Change turnover 6,298 Less Arrow -4,456 More Arrow 1,832
Change turnover % 66% Less Arrow -31% More Arrow 15%
Chg. No. of employees -29 More Arrow 16 Less Arrow 5
Chg. No. of employees % -20% More Arrow 12% Less Arrow 4%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.